首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1690007

過敏性鼻炎市場規模、佔有率及成長分析（按類型、治療、給藥途徑、劑型、檢測方法、分銷管道和地區）－2025-2032 年產業預測

Allergic Rhinitis Market Size, Share, and Growth Analysis, By Type (Seasonal, Perennial), By Treatment (Immunotherapy, Antihistamines), By Route of Administration, By Form, By Test, By Distribution Channel, By Region - Industry Forecast 2025-2032

出版日期: 2025年03月24日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計過敏性鼻炎市場規模將在 2023 年達到 118 億美元，並從 2024 年的 122.4 億美元成長到 2032 年的 163.6 億美元，預測期內（2025-2032 年）的複合年成長率為 3.7%。

過敏性鼻炎市場的發展受到過敏性疾病盛行率上升、環境條件變化以及治療方案意識增強的推動。主要成長動力包括創新治療藥物的開發、初級醫療保健支出的增加以及旨在尋找更有效治療方法的持續研究。然而，非處方藥供應等挑戰正在影響處方藥的銷售。市場由大型製藥企業主導，這些公司主要致力於推進免疫療法解決方案。治療方法的不斷改進和向個人化醫療的轉變等積極趨勢正在塑造過敏性鼻炎的未來前景。總體而言，該市場在治療過敏性疾病方面顯示出巨大的成長和創新潛力。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

ALK-Abello A/S（Denmark）
Chiesi Farmaceutici SpA（Italy）
Sun Pharmaceutical Industries Limited（India）
Teva Active Pharmaceutical Ingredients（Israel）
GlaxoSmithKline plc（United Kingdom）
Merck & Co., Inc.（USA）
AstraZeneca plc（United Kingdom）
Novartis International AG（Switzerland）
Pfizer Inc.（USA）
Johnson & Johnson（USA）
Bayer AG（Germany）
Roche Holding AG（Switzerland）
AbbVie Inc.（USA）
Eli Lilly and Company（USA）
Boehringer Ingelheim GmbH（Germany）
Takeda Pharmaceutical Company Limited（Japan）
Mylan NV（USA）
Cipla Limited（India）
Dr. Reddy's Laboratories（India）

結論和建議

簡介目錄

Product Code: SQMIG35D2216

Allergic Rhinitis Market size was valued at USD 11.8 billion in 2023 and is poised to grow from USD 12.24 billion in 2024 to USD 16.36 billion by 2032, growing at a CAGR of 3.7% during the forecast period (2025-2032).

The allergic rhinitis market is being propelled by the rising prevalence of allergic disorders, shifting environmental conditions, and heightened awareness of treatment options. Key growth drivers include the development of innovative therapeutics, increasing healthcare expenditures, and ongoing research aimed at discovering more effective treatments. However, challenges such as the availability of over-the-counter medications are affecting prescription sales. The market is dominated by major pharmaceutical companies, with a significant focus on advancing immunotherapy solutions. Positive trends include continuous enhancements in treatment modalities and a shift towards personalized medicine, which are shaping the future of the allergic rhinitis landscape. Overall, the market exhibits considerable potential for growth and innovation in addressing allergic conditions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Allergic Rhinitis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Allergic Rhinitis Market Segments Analysis

Global Allergic Rhinitis Market is segmented by Type, Treatment, Route of Administration, Form, Test, Distribution Channel and region. Based on Type, the market is segmented into Seasonal, Perennial and Occupational Rhinitis. Based on Treatment, the market is segmented into Immunotherapy, Antihistamines, Decongestants, Vertebral Fusion, Corticosteroids and Others. Based on Route of Administration, the market is segmented into Oral, Parenteral and Intranasal. Based on Form, the market is segmented into Solid and Liquid. Based on Test, the market is segmented into Skin Test, IgE RAST Test and Complete Blood Count. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Allergic Rhinitis Market

The global allergic rhinitis market is significantly propelled by the rising prevalence of the condition, influenced by environmental factors and lifestyle changes. This surge can be attributed to factors such as urbanization, heightened pollution levels, and increased exposure to allergens, all of which contribute to a higher demand for effective treatment solutions. As more individuals experience the discomfort associated with allergic rhinitis, the need for innovative therapies and management strategies is becoming increasingly critical, thereby driving growth within the market and prompting the development of new and enhanced treatments to address this widespread issue.

Restraints in the Allergic Rhinitis Market

A significant restraint in the allergic rhinitis market is the frequent underdiagnosis and undertreatment of the condition, primarily due to limited awareness and misunderstanding of symptoms among both patients and healthcare professionals. This issue is compounded by challenges related to access and affordability of medications, particularly in developing regions, which hinders effective management. Moreover, the complexities of regulatory frameworks and discrepancies in approval processes for allergy medications can impede market growth and the introduction of innovative treatment solutions. Addressing these barriers is essential for enhancing patient outcomes and advancing the overall market for allergic rhinitis.

Market Trends of the Allergic Rhinitis Market

The Allergic Rhinitis market is witnessing a significant shift towards precision medicine and personalized treatment approaches, reflecting an evolving understanding of individual patient profiles and allergen sensitivities. This trend emphasizes tailored interventions, allowing for more effective management of symptoms based on specific characteristics of each patient. Moreover, immunotherapy, particularly through sublingual and subcutaneous methods, is gaining traction as a long-term strategy for altering the disease's trajectory, rather than just managing symptoms. This evolution in treatment methodologies not only enhances patient outcomes but also fosters greater adherence to therapy, thereby driving market growth and innovation in the field of allergic rhinitis management.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Allergic Rhinitis Market Size by Type & CAGR (2025-2032)

Market Overview
Seasonal
Perennial
Occupational Rhinitis

Global Allergic Rhinitis Market Size by Treatment & CAGR (2025-2032)

Market Overview
Immunotherapy
Antihistamines
Decongestants
Vertebral Fusion
Corticosteroids
Others

Global Allergic Rhinitis Market Size by Route of Administration & CAGR (2025-2032)

Market Overview
Oral
Parenteral
Intranasal

Global Allergic Rhinitis Market Size by Form & CAGR (2025-2032)

Market Overview
Solid
Liquid

Global Allergic Rhinitis Market Size by Test & CAGR (2025-2032)

Market Overview
Skin Test
IgE RAST Test
Complete Blood Count

Global Allergic Rhinitis Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Hospital Pharmacies
Retail Pharmacies
Online Stores

Global Allergic Rhinitis Market Size & CAGR (2025-2032)

North America (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
- US
- Canada
Europe (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Treatment, Route of Administration, Form, Test, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

ALK-Abello A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chiesi Farmaceutici S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Active Pharmaceutical Ingredients (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck & Co., Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca plc (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis International AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Holding AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan N.V. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cipla Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dr. Reddy's Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments